Tennessee 114th General Assembly Status: Enacted 1 R cosponsors

SB 1848 — AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.

Last action — Comp. became Pub. Ch. 753

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 21, 2026. Enacted.

Signed by Governor Bill Lee (Republican) on April 06, 2026.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 72% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

Bill Text

Action History

  1. Filed for introduction

  2. Intro., P1C.

  3. P2C, ref. to Health Committee

  4. Assigned to s/c Health Subcommittee

  5. Sponsor change.

  6. Sponsor(s) withdrawn.

  7. Placed on s/c cal Health Subcommittee for 2/18/2026

  8. Sponsor(s) Added.

  9. Rec. for pass by s/c ref. to Health Committee

  10. Sponsor(s) Added.

  11. Placed on cal. Health Committee for 3/3/2026

  12. Action def. in Health Committee to 3/10/2026

  13. Placed on cal. Health Committee for 3/10/2026

  14. No Action Taken

  15. Placed on cal. Health Committee for 3/17/2026

  16. Rec. for pass; ref to Calendar & Rules Committee

  17. Placed on cal. Calendar & Rules Committee for 3/26/2026

  18. H. Placed on Consent Calendar for 3/30/2026

  19. Passed H., Ayes 82, Nays 1, PNV 10

  20. Engrossed; ready for transmission to Sen.

  21. Sponsor(s) Added.

  22. Received from House, Passed on First Consideration

  23. Senate substituted House Bill for companion Senate Bill.

  24. Passed Senate, Ayes 28, Nays 3

  25. Enrolled; ready for sig. of H. Speaker.

  26. Signed by H. Speaker

  27. Signed by Senate Speaker

  28. Transmitted to Governor for his action.

  29. Signed by Governor.

  30. Pub. Ch. 753

  31. Effective date(s) 04/16/2026

  32. Filed for introduction

  33. Introduced, Passed on First Consideration

  34. Passed on Second Consideration, refer to Senate Health and Welfare Committee

  35. Placed on Senate Health and Welfare Committee calendar for 2/18/2026

  36. Action deferred in Senate Health and Welfare Committee to 3/4/2026

  37. Placed on Senate Health and Welfare Committee calendar for 3/11/2026

  38. Action deferred in Senate Health and Welfare Committee to 3/18/2026

  39. Placed on Senate Health and Welfare Committee calendar for 3/17/2026

  40. Action deferred in Senate Health and Welfare Committee to 3/18/2026

  41. Placed on Senate Health and Welfare Committee calendar for 3/18/2026

  42. Recommended for passage, refer to Senate Calendar Committee

  43. Placed on Senate Regular Calendar for 3/30/2026

  44. Companion House Bill substituted

  45. Comp. became Pub. Ch. 753

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 132 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (132)

132 members have not signed on to this bill.

Show all 132 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 1848 do?
Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
Who sponsors SB 1848?
SB 1848 is sponsored by Massey, Becky D. (Republican).
What is the current status of SB 1848?
This bill has been enacted into law. Introduced January 21, 2026. Enacted.
Where can I track SB 1848?
Track SB 1848 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1848

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1848

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →